ITOS iTeos Therapeutics: Forvard P/S multiplikatori
iTeos Therapeutics (ITOS) immuno-onkologiya sohasidagi istiqbolli ishtirokchi bo'lib, saraton bilan kurashish uchun inqilobiy molekulalar ishlab chiqmoqda. Kompaniyaning kelajakdagi P/S ko'rsatkichi aks etgan ushbu grafik bozor kutganlarini vizuallashtiradi, 11.00 esa ushbu metrikaning joriy qiymatini ko'rsatadi. Sog'liqni saqlashga bo'lgan barqaror talab aktivga defensiv xususiyatlar beradi, AQSh va Belgiya ekspertlari o'rtasidagi sinergiya esa dadil ilmiy g'oyalar rivojlanishini ta'minlaydi.
ITOS (iTeos Pharma): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati iTeos Therapeutics|ITOS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati iTeos Therapeutics|ITOS - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans qiymatiga nisbati iTeos Pharma|ITOS - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari iTeos Therapeutics|Tezkor likvidlik koeffitsiyenti iteostherapeutics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ITOS - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda iTeos Therapeutics|ITOS - Kapitalizatsiyaning foydaga nisbati|Kelajakdagi narxning foydaga nisbati iTeos|ITOS - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori iTeos Pharma|ITOS - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda iTeos Therapeutics|ITOS - So'nggi 12 oy davomida bitta aksiya uchun foyda|Choraklik EPS foyda o'sishi iteostherapeutics.com|ITOS - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi iTeos Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning har tomonlama tahlili:iTeos Therapeutics, Inc. (ITOS)
iTeos Therapeutics (ITOS) barqarorligi tadqiqot va ishlanmalar (R&D) patent himoyasi hamda sog'liqni saqlash gigantlari bilan strategik ittifoqlari bilan mustahkamlanib, bu mustahkam moliyaviy poydevorni shakllantiradi. Oldindan bashorat qilingan P/S koeffitsiyenti tendentsiyasi bozor kapitalizatsiyasi va kutilayotgan savdo hajmi o'rtasidagi bog'liqlikni aks ettirib, investorlarga kelajakdagi o'sish uchun to'langan premiumni baholash hamda spekulyativ kutishlar va biznesning haqiqiy fundamental salohiyati o'rtasidagi adolatli muvozanatni aniqlash imkonini beradi.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|PTGX (Protagonist Therapeutics) - Forvard narx/daromad multiplikatori|IMVT: Narxning kutilayotgan daromadga nisbati|KNSA (Kiniksa) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grifols SA GRFS|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|CLDX - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|Kapitalizatsiyaning kutilayotgan sotuvga nisbati biocryst.com (BCRX)|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics Inc)|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|ABCL: Narxning kutilayotgan daromadga nisbati|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|PGEN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PHAR|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|Sotuvga nisbatan forvard narx ZBIO|Immunome, Inc. - Forvard P/S multiplikatori|GOSS - Forvard P/S multiplikatori|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati SEPN (Septerna, Inc.)|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Savara Pharma SVRA|Forvard narx/daromad multiplikatori RIGL (Rigel Pharmaceuticals)|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ENGN (enGene Holdings Inc)|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aerovate Therapeutics Inc JBIO|ACRS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori kyvernatx.com|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori VTYX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Theratechnologies, Inc|Avalo Therapeutics, Inc - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ELDN (eledon.com)|AGEN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Climb Bio Inc.|Zura Bio Limited (ZURA) - Narxning prognoz qilingan daromadga nisbati|ATYR - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Ikena Oncology, Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori STTK|EQ (equilliumbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Adicet Bio, Inc.|CELU (Celularity Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori INmune Bio Corporation|Forvard narx/daromad multiplikatori BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics PLC (AKTX)|ENLV - Narxning prognoz qilingan daromadga nisbati|Q32 Bio Inc. (QTTB) - Forvard narx/daromad multiplikatori|GeoVax Labs, Inc. (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori edesabiotech.com|Forvard narx/daromad multiplikatori IBIO|Forvard P/S multiplikatori Carisma Tx|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|boltbio.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori HCWB (HCW Biologics)|Aptevo Therapeutics, Inc. (APVO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AIM ImmunoTech - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aditxt ADTX|GRI (GRI Bio Corp) - Forvard narx/daromad multiplikatori|XRTX: Narxning kutilayotgan daromadga nisbati|HIND (Vyome Holdings Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati revbiosciences.com REVB|Narxning prognoz qilingan daromadga nisbati Indaptus Therapeutics, Inc. (INDP)|SCNI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati CalciMedica CALI|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Affimed NV (AFMD)|ALLK: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx HOOK (HOOKIPA Pharma Inc.)|IGMS (igmbio.com) - Forvard narx/daromad multiplikatori|OCEA: Narxning kutilayotgan daromadga nisbati|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|THRD: Sotuvga nisbatan forvard narx
